Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

TSO3 Inc T.TOS

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies

TSO3 Inc is engaged in the sale, production, maintenance, research, development & licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices.
Price: $1.65 | Change: $-0.05 | %Change: -2.94%
Volume: 34,269 | Day High/Low: N/A/N/A | 52 Week High/Low: 1.88/0.51
View modes: 
5 stars

Dr. Cash

There is to much talk about the crisis, the vp4 is hands down better then any other sterilizer out in the field so even with out the crisis we should be seeing sales soon. The crisis fix is a bonus in...read more
1 star

RE:RE:RE:RE:RE:Post FDA meeting article

So Mr. Rumble has recently been reticent regarding trumpeting the VP4 as the instant, disruptive and final solution to this current crisis._____To what extent is this simply because he doesn't HAVE...read more
0 stars

RE:RE:RE:RE:Post FDA meeting article

Thanks for filling in some blanks with Rumble's comments. However I can't agree with any of your conclusions, (sample below) considering Rumble has the facts and we do not really have ANY, so this...read more
5 stars

RE:RE:RE:Post FDA meeting article

Immediately before the start of the AGM I asked Rumble if TSO3 would be making a presentation at the FDA conference. When he replied no I then asked why not. His reply was that the important people...read more
5 stars

RE:RE:Post FDA meeting article

From slide 47 of those used during the AGM: "Les données internes de Tso3 appuient la possibilité d'exploiter les revendications d'usage accrues des autorisations(pas une nouvelle autorisation) des...read more
5 stars

RE:Post FDA meeting article

In the article it says " dearth of data Is part of why the panel did not settle on any one best practice for sterilization ".  Has anyone asked Rumble if Tos submitted data showing Cre effectively...read more
0 stars

Post FDA meeting article

FDA advisory panel: Superbug-linked scopes put patients in danger Experts criticize manufacturer Olympus, but say devices should stay on market May 18, 2015 | By Leslie Small SHARE ...read more
5 stars

RE:The FDA at it's Best!

Sorry guys, was away tending to the flower beds during the WE. Someone left a message saying that the URL in the original "The FDA at it's Best" seems broken. Indeed, for some unknown reason, it doesn...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A Quick Reaction -- FDA Meeting

Since none of the three regular paid analysts would commit an opinion after the FDA meeting, our best resource is without doubt the analysis provided here by echo2 in his post of May 17. Meanwhile...read more
0 stars

RE:RE:The FDA at it's Best!

They would rather do nothing for years rather than make a mistake approving something they hadn't studied for a few years longer than anyone else would take to study it. It is surprising the analysts...read more
0 stars

RE:The FDA at it's Best!

How they cannot be already on the phone and begging TSO3 to file for the duodenoscopes sterilisation claims is a mystery to me.  rate and reply
5 stars

The FDA at it's Best!

Without comments http://www.usatoday.com/story/news/2015/05/21/fda-missed-warnings-on-medical-scope-superbug-risks/27653529/  rate and reply
5 stars

Advertisement in Outpatient Surgery

http://www.outpatientsurgery.net/did-you-see-this/2015/05/tso3-sterizone-vp4-sterilizer Finally, A Low-Temperature Sterilizer That’s Economical, Efficient and Easy to Operate   Sterilize big...read more
0 stars

RE:RE:insider trading

Please correct me if I am mistaken but it appears to me that Germain Carrière,president and Chief Operating Officer of Desjardins Securities, simply sold 15,000 shares and exercised his warrants for...read more
0 stars

RE:insider trading

This is nothing and meaningless. It is tax time, a daughter needs braces, or whatever. Give us a break. Even I sold more than 10,000 shares over the past month, though I picked up many times more than...read more
0 stars

insider trading

May 15/15 May 15/15 Carrière, Germain Direct Ownership Common Shares 10 - Disposition in the public market -7,100 $1.66 May 15/15 May 15/15 Carrière, Germain Direct Ownership Common Shares 10...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:A Quick Reaction -- FDA Meeting

Eunice, you know everything in life! On the eve of the FDA meeting, the analyst of Desjardins wrote a short piece to say he had reviewed all the material and that he would "monitor panel discussions...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:A Quick Reaction -- FDA Meeting

The analysts will likely write this up early this week and perhaps Rumble will put out an update.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:A Quick Reaction -- FDA Meeting

As lematou points out scopes were filed for claim but the ones in question in the states are 1 metre and have a lumen of 3/4 inches I believe. These can be easily sterilize d by Tos.   Not sure w why...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:RE:A Quick Reaction -- FDA Meeting

From the fact sheet on the Tso3 web site, 850 mm flexible bronchoscopes were part of loads used to validate the 510(k) application. Meanwhile, a quick survey of the specs of the Olympus bronchosopes...read more